Cargando…
The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML)
SIMPLE SUMMARY: AML is a type of leukemia with a very unfavorable prognosis. Some of the new therapeutic targets that are being investigated by researchers worldwide are chemokines of the CXC subfamily, which includes CXCL12. Although this chemokine has been very well studied, other CXC chemokines h...
Autores principales: | Korbecki, Jan, Kupnicka, Patrycja, Barczak, Katarzyna, Bosiacki, Mateusz, Ziętek, Paweł, Chlubek, Dariusz, Baranowska-Bosiacka, Irena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526350/ https://www.ncbi.nlm.nih.gov/pubmed/37760523 http://dx.doi.org/10.3390/cancers15184555 |
Ejemplares similares
-
Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes
por: Korbecki, Jan, et al.
Publicado: (2023) -
CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer
por: Korbecki, Jan, et al.
Publicado: (2022) -
Targeting CXCR4 in AML and ALL
por: Cancilla, Daniel, et al.
Publicado: (2020) -
Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands
por: Moussouras, Natasha A., et al.
Publicado: (2017) -
Computer‐aided assessment of the chemokine receptors CXCR3, CXCR4 and CXCR7 expression in gallbladder carcinoma
por: Yu, Xiao, et al.
Publicado: (2020)